{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:06Z","timestamp":1791326106104,"version":"4.3.1"},"reference-count":135,"publisher":"Informa UK Limited","issue":"10","funder":[{"name":"Chris McGuigan\u2019s laboratory at Cardiff University"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Discovery"],"published-print":{"date-parts":[[2021,10,3]]},"DOI":"10.1080\/17460441.2021.1922385","type":"journal-article","created":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:38:55Z","timestamp":1620977935000},"page":"1149-1161","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":50,"title":["An overview of ProTide technology and its implications to drug discovery"],"prefix":"10.1080","volume":"16","author":[{"given":"Michaela","family":"Serpi","sequence":"first","affiliation":[{"name":"School of Chemistry, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Pertusati","sequence":"additional","affiliation":[{"name":"School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1038\/182421a0"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-49785-3"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2018.46"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4010"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-7258(00)00048-6"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1021\/cr5002035"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1002\/1098-1128(200011)20:6<417::AID-MED1>3.0.CO;2-Z"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1016\/S0968-0896(02)00552-7"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1007\/128_2014_561"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.3851\/IMP2012"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1517\/17425240902824808"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1021\/jm00060a013"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b00734"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.8b00586"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.056135"},{"issue":"4","key":"cit0016","first-page":"693","volume":"56","author":"Saboulard D","year":"1999","journal-title":"Mol Pharmacol"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1177\/095632029800900202"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.161802"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1039\/C8OB02870B"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1021\/jm200815w"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1124\/mol.59.3.446"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2017.04.013"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1002\/0471142700.nc1505s53"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1021\/acs.orglett.7b00469"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1039\/C9RA01754B"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002338"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-100002495"},{"key":"cit0028","doi-asserted-by":"publisher","DOI":"10.1021\/jm100863x"},{"key":"cit0029","doi-asserted-by":"publisher","DOI":"10.1021\/jm401853a"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2014.03.051"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1021\/jm100817f"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.1021\/jo201492m"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1039\/C5CC00448A"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.1126\/science.aam7936"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)00128-7"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.1002\/cpnc.56"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2018.01.086"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(91)90071-X"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(92)81322-D"},{"key":"cit0040","doi-asserted-by":"publisher","DOI":"10.1021\/jm9807104"},{"key":"cit0041","doi-asserted-by":"publisher","DOI":"10.1021\/jm950605j"},{"key":"cit0042","doi-asserted-by":"publisher","DOI":"10.1021\/jm9803931"},{"key":"cit0043","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)00616-9"},{"key":"cit0044","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-120025242"},{"key":"cit0045","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2007.04.043"},{"key":"cit0046","doi-asserted-by":"publisher","DOI":"10.1021\/jm0491400"},{"key":"cit0047","doi-asserted-by":"publisher","DOI":"10.1021\/jm060776w"},{"key":"cit0048","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-200040678"},{"key":"cit0049","doi-asserted-by":"publisher","DOI":"10.4172\/2155-6113.1000138"},{"key":"cit0050","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.201200562"},{"key":"cit0051","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2012.01.007"},{"key":"cit0052","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2010.02.015"},{"key":"cit0053","doi-asserted-by":"publisher","DOI":"10.1021\/jo500659e"},{"key":"cit0054","doi-asserted-by":"publisher","DOI":"10.1021\/jm0613370"},{"key":"cit0055","doi-asserted-by":"publisher","DOI":"10.1021\/jm070362i"},{"key":"cit0056","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.05.099"},{"key":"cit0057","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2009.03.138"},{"key":"cit0058","doi-asserted-by":"publisher","DOI":"10.1021\/jm1003792"},{"key":"cit0059","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2010.06.094"},{"key":"cit0060","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01335-10"},{"key":"cit0061","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2013.11.008"},{"key":"cit0062","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2012.11.018"},{"key":"cit0063","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214854"},{"key":"cit0064","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.08.029"},{"issue":"11","key":"cit0065","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S2468-1253(17)30159-0","volume":"2","author":"Gane EJ","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"cit0066","doi-asserted-by":"publisher","DOI":"10.1021\/jm400201a"},{"key":"cit0067","first-page":"S470","volume":"56","author":"Lawitz E","year":"2012","journal-title":"J Hepatol"},{"key":"cit0068","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01594"},{"key":"cit0069","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910993"},{"key":"cit0070","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aal3653"},{"key":"cit0071","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107940"},{"key":"cit0072","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1922083117"},{"key":"cit0073","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0282-0"},{"key":"cit0074","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2007764"},{"key":"cit0075","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015301"},{"key":"cit0076","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"cit0077","unstructured":"Repurposed antiviral drugs for Covid-19 \u2014 interim WHO solidarity trial results. N Engl J Med. 2020."},{"key":"cit0078","unstructured":"https:\/\/www.who.int\/news-room\/feature-stories\/detail\/who-recommends-against-the-use-of-remdesivir-in-covid-19-patients."},{"key":"cit0079","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2008.06.069"},{"key":"cit0080","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01009"},{"key":"cit0081","doi-asserted-by":"publisher","DOI":"10.1086\/650343"},{"key":"cit0082","doi-asserted-by":"publisher","DOI":"10.1021\/jm9007856"},{"key":"cit0083","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2011.03.027"},{"key":"cit0084","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1877"},{"key":"cit0085","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.4.569-596.2003"},{"key":"cit0086","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2006.09.014"},{"key":"cit0087","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.5.1898-1906.2005"},{"key":"cit0088","unstructured":"U.S. Food and Drug Administration Approves Gilead\u2019s single tablet regimen Genvoya\u00ae (Elvitegravir, cobicistat, emtricitabine and tenofovir alafenamide) for Treatment of HIV-1 infection in. https:\/\/www.businesswire.com\/news\/home\/20151105006409\/en\/U.S.Food-and-Drug-Administration-Approves-Gilead%E2%80%99s-Single-Tablet-Regimen-Genvoya%C2%AE-Elvitegravir-Cobicistat-Emtricitabine-and-Tenofovir-Alafenamide-for-Treatment-of-HIV-1-Infection20210412."},{"key":"cit0089","unstructured":"U.S. Food and Drug Administration Approves Gilead\u2019s Vemlidy\u00ae (Tenofovir Alafenamide) for the treatment of chronic hepatitis B virus infection in. https:\/\/www.gilead.com\/news-and-press\/press-room\/press-releases\/2016\/11\/us-food-and-drug-administration-approves-gileads-vemlidy-tenofovir-alafenamide-for-the-treatment-of-chronic-hepatitis-b-virus-infection.20210412"},{"key":"cit0090","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00542-6"},{"key":"cit0091","doi-asserted-by":"publisher","DOI":"10.1177\/095632020101200504"},{"key":"cit0092","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(02)80748-1"},{"key":"cit0093","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2005.02.041"},{"key":"cit0094","doi-asserted-by":"publisher","DOI":"10.1021\/jm0509896"},{"key":"cit0095","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.10.077"},{"key":"cit0096","doi-asserted-by":"publisher","DOI":"10.1021\/jm8005965"},{"key":"cit0097","unstructured":"University of Oxford. NUC-3373 in advanced solid tumours (NuTide:301) In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02723240.NLMidentifier:NCT02723240."},{"key":"cit0098","unstructured":"NuCana plc. A Safety Study of NUC-3373 in combination with standard agents used in colorectal cancer treatment In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03428958.NLMidentifier:NCT03428958"},{"key":"cit0099","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.11.037"},{"key":"cit0100","unstructured":"Imperial College London. NUC-1031 in patients with advanced solid tumours (ProGem1) In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT01621854.NLMidentifier:NCT01621854"},{"key":"cit0101","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-018-0244-1"},{"key":"cit0102","unstructured":"NuCana plc. NUC-1031 in patients with platinum-resistant ovarian cancer. In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03146663.NLMidentifier:NCT03146663."},{"key":"cit0103","unstructured":"The Christie NHS Foundation Trust. ABC-08: phase Ib trial of acelarin in combination with cisplatin in locally advanced\/metastatic biliary tract cancers (ABC-08). In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02351765.NLMidentifier:NCT02351765."},{"key":"cit0104","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-020-04079-z"},{"key":"cit0105","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2020-0247"},{"key":"cit0106","unstructured":"Griffith HM, Christopher; Ferrari, Valentina; Serpi, Michaela. New 2\u02b9 and\/or 5\u02b9 amino-acid ester phosphoramidate 3\u02b9-deoxyadenosine derivatives as anticancer compounds. From PCT Int. Appl. (2016),WO2016083830A120160602."},{"key":"cit0107","unstructured":"NuCana plc. A safety study of NUC-7738 in patients with advanced solid tumours or lymphoma. In: ClinicalTrials.gov [internet] National Library of Medicine [cited 2021 Apr 12] available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03829254.NLMidentifier:NCT03829254"},{"key":"cit0108","doi-asserted-by":"publisher","DOI":"10.1002\/open.201700019"},{"key":"cit0109","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25030704"},{"key":"cit0110","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.00952"},{"key":"cit0111","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b00325"},{"key":"cit0112","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.14.166"},{"key":"cit0113","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkx151"},{"key":"cit0114","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2014.02.056"},{"key":"cit0115","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.6b01897"},{"key":"cit0116","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12354"},{"key":"cit0117","doi-asserted-by":"publisher","DOI":"10.1021\/jm800594c"},{"key":"cit0118","doi-asserted-by":"publisher","DOI":"10.1021\/jm300074y"},{"key":"cit0119","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00833"},{"key":"cit0120","doi-asserted-by":"publisher","DOI":"10.1016\/j.tet.2013.08.038"},{"key":"cit0121","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2013.02.117"},{"key":"cit0122","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.200700040"},{"key":"cit0123","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202000034"},{"key":"cit0124","doi-asserted-by":"publisher","DOI":"10.1039\/C8MD00244D"},{"key":"cit0125","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b00655"},{"key":"cit0126","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01824"},{"key":"cit0127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2019.103012"},{"key":"cit0128","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2017.02.011"},{"key":"cit0129","doi-asserted-by":"publisher","DOI":"10.1021\/acsmedchemlett.0c00170"},{"key":"cit0130","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2016.03.076"},{"key":"cit0131","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.9b00833"},{"key":"cit0132","unstructured":"Lloyd-Evans E, Pertusati F, James E, et al. Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulators patent WO2019064012A1. 2019."},{"key":"cit0133","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.7b01009"},{"key":"cit0134","doi-asserted-by":"publisher","DOI":"10.21037\/atm.2018.10.45"},{"key":"cit0135","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10284"}],"container-title":["Expert Opinion on Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17460441.2021.1922385","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,21]],"date-time":"2021-09-21T13:53:49Z","timestamp":1632232429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17460441.2021.1922385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":135,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10,3]]}},"alternative-id":["10.1080\/17460441.2021.1922385"],"URL":"https:\/\/doi.org\/10.1080\/17460441.2021.1922385","relation":{},"ISSN":["1746-0441","1746-045X"],"issn-type":[{"value":"1746-0441","type":"print"},{"value":"1746-045X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedc20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}